Trump's deadlines for tariffs, federal worker buyouts and RTO, federal funding freeze, TikTok, and more are coming up. Here's ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Although several companies have cut or scaled back DEI programs, Target's reversal on DEI seemed to draw the greatest outrage ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on DHR stock, giving a Buy rating yesterday.Invest with Confidence: ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, Intel edges higher after revenue projections miss analysts’ estimates, and Chevron posts ...

A meeting was held at the Ministry of Health, on 28th January 2025, presided by Minister of Health, Dr. Nalinda Jayatissa at ...

The results of a phase 2 trial of MSD’s ROR1 inhibitor zilovertamab vedotin (zilo-V) back up the company's decision to push the antibody-drug conjugate (ADC) into a phase 3 programme.

“Love Me” is a futuristic drama about an existential romance between a smart buoy, portrayed by Stewart, and a satellite, ...

The 22-year-old marked his debut with the Australian side in style, scoring a try against the Hurricanes. Now, as he gears up ...